Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and suspensions, creams, gel, ORS, jelly, gynae, inhalers, opthal, ortho, and pediatrics formulations in dosage forms. It also provides life care, evolve, and the right nutrition products under the Cratus brand. In addition, the company offers its pharmaceutical formulation products in various dosage forms, such as tablets, capsules, ointments, injections, liquids orals, and effervescent. Syncom Formulations (India) Limited was incorporated in 1988 and is based in Indore, India.
Metrics to compare | SYFI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSYFIPeersSector | |
---|---|---|---|---|
P/E Ratio | 28.0x | 27.6x | −0.6x | |
PEG Ratio | 0.40 | 0.14 | 0.00 | |
Price/Book | 4.7x | 3.2x | 2.6x | |
Price / LTM Sales | 3.3x | 2.2x | 3.3x | |
Upside (Analyst Target) | - | 13.8% | 38.7% | |
Fair Value Upside | Unlock | 1.4% | 4.5% | Unlock |